Article info
Basic and translational research
Extended report
Anti-inflammatory effects of cell-based therapy with tyrosine hydroxylase-positive catecholaminergic cells in experimental arthritis
- Correspondence to Dr Rainer H Straub, Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine, University Hospital Regensburg, Biopark I, Josef Engert Str. 9, Regensburg, Bavaria 93053, Germany; rainer.straub{at}ukr.de
Citation
Anti-inflammatory effects of cell-based therapy with tyrosine hydroxylase-positive catecholaminergic cells in experimental arthritis
Publication history
- Received May 10, 2013
- Revised September 10, 2013
- Accepted November 10, 2013
- First published December 2, 2013.
Online issue publication
January 07, 2015
Article Versions
- Previous version (2 December 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions